Treatment outcomes and predicting factors for diabetic macular edema treated with ranibizumab - One-year real-life results in Taiwan.

CONCLUSION: Compared with existing prospective studies, the one-year real-life data in Taiwan showed fewer ranibizumab injections for DME and a less prominent yet still significant visual improvement. Both visual and anatomical improvements at Month 3 were correlated with the level of improvements at Month 12. Previous subtenon steroid injection might reduce the need of additional ranibizumab injections.
PMID: 29609918 [PubMed - as supplied by publisher]

Source: J Formos Med Assoc - March 30, 2018 Category: General Medicine Authors: Lai TT, Yang CM, Yang CH, Ho TC, Hsieh YT Tags: J Formos Med Assoc Source Type: research